Dublin, Sept. 19, 2023 (GLOBE NEWSWIRE) -- The "Lung Cancer Screening Market Size and Forecast to 2030 - Global Analysis by Cancer Type [Non-Small Cell Lung Cancer and Small Cell Lung Cancer], Technology [Low-Dose Computed Tomography, Chest X-Ray, Liquid Biopsy, and Others], Age Group, and End User" report has been added to ResearchAndMarkets.com's offering.
The Lung Cancer Screening market is poised for significant growth, with an anticipated increase from US$ 2,326.5 million in 2022 to US$ 4,363.95 million by 2030, representing a compound annual growth rate (CAGR) of 8.2% during this period. The key drivers of this growth are the increasing incidence of lung cancer and growing government support. However, the high cost of lung screening tests poses a challenge to market expansion.
Market Drivers:
- Rising Lung Cancer Incidences: The prevalence of lung cancer is on the rise, contributing to the growing demand for lung cancer screening services.
- Increasing Government Support: Government recommendations and support for lung cancer screening programs, such as the United States Preventive Services Task Force's guidelines, are boosting market growth.
Market Restraints:
- High Cost of Lung Cancer Screening Tests: The cost associated with lung cancer screening tests is a significant restraint in the market's expansion, potentially limiting accessibility for some individuals.
Market Opportunities:
- Structured Lung Cancer Screening Programs: Implementing structured lung cancer screening programs can provide new opportunities for market growth, ensuring more individuals have access to screening services.
Future Trends:
- Mobile Lung Cancer Screening Trucks: The emergence of mobile lung cancer screening trucks could become a prominent trend, offering convenient and accessible screening services to a wider population.
Key Players:
- Intelerad Medical Systems Incorporated
- Nuance Communications Inc
- GE HealthCare Technologies Inc
- Medtronic Plc
- Canon Medical Systems Corp
- Koninklijke Philips NV
- Siemens AG
- CVS Health
- bioAffinity Technologies, Inc.
- LungLife AI, Inc.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 188 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value (USD) in 2022 | $2.33 Billion |
| Forecasted Market Value (USD) by 2030 | $4.36 Billion |
| Compound Annual Growth Rate | 8.2% |
| Regions Covered | Global |
For more information about this report visit https://www.researchandmarkets.com/r/fabi2z
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
